Higher LDL Cholesterol and Oxidative Stress: Understanding Lipid Oxidation and Antioxidant Defense

Introduction

Low-density lipoprotein (LDL) is a lipoprotein particle responsible for transporting cholesterol from the liver to peripheral tissues. Although cholesterol is essential for cell membranes, steroid hormone synthesis, and other biological functions, elevated levels of LDL cholesterol in the bloodstream are associated with an increased risk of atherosclerotic cardiovascular disease.

Beyond the quantity of circulating LDL, the biochemical properties of LDL particles may influence their susceptibility to oxidative modification. Oxidized LDL (oxLDL) has been extensively investigated for its role in endothelial dysfunction, inflammation, and the development of atherosclerotic plaques.

A study by B. J. Mosinger, published in Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, examined how cholesterol content within LDL particles affects oxidation kinetics and the effectiveness of antioxidant protection. By combining experimental observations with computer simulations, the research provided insight into the relationship between LDL composition, lipid oxidation, and antioxidant defense.

What Is LDL Cholesterol?

Low-density lipoprotein is a complex particle composed of lipids and proteins. Its main structural components include:

Cholesterol: A lipid required for cell membrane structure and hormone production.

Cholesteryl esters: Cholesterol molecules esterified with fatty acids and stored within the particle's hydrophobic core.

Phospholipids: Molecules that contribute to the particle's outer surface.

Apolipoprotein B-100 (ApoB-100): The principal structural protein of LDL, involved in receptor recognition and particle metabolism.

The composition of LDL can vary depending on metabolic conditions and other biological factors. These differences may influence particle stability, lipid organization, and susceptibility to oxidative damage.

Importantly, the cholesterol content of an individual LDL particle is not the same as the concentration of LDL cholesterol measured in blood. These are related but distinct parameters.

Understanding LDL Oxidation

LDL oxidation occurs when reactive chemical species modify lipids and, under certain conditions, proteins associated with the particle. Polyunsaturated fatty acids in LDL are particularly susceptible to lipid peroxidation.

Lipid oxidation can proceed through a chain reaction involving the initiation, propagation, and termination of radical reactions. During this process, lipid hydroperoxides and secondary oxidation products may accumulate.

Oxidatively modified LDL can interact differently with cells than native LDL. In experimental models, oxLDL can promote inflammatory signaling, contribute to macrophage lipid accumulation, and support the formation of foam cells.

Foam cells are lipid-loaded cells found in early atherosclerotic lesions. Their accumulation, together with inflammation and other vascular changes, contributes to plaque development.

However, LDL oxidation is a complex biological process. Results obtained in isolated particles or laboratory models do not necessarily reproduce every aspect of oxidation occurring within human arteries.

How Does Higher Cholesterol Content Affect LDL Oxidation?

The study by Mosinger investigated the relationship between LDL cholesterol content and the kinetics of LDL oxidation. Its findings indicated that LDL particles containing more cholesterol oxidized more rapidly under the experimental conditions studied.

The researchers also observed that higher cholesterol content was associated with greater resistance to the antioxidant effect of ascorbic acid, commonly known as vitamin C.

These findings suggest that the relationship between LDL composition and oxidation is more complex than simply measuring the amount of cholesterol present.

Acceleration of oxidation

The researchers reported that increasing cholesterol content in LDL was associated with accelerated oxidation. The oxidation rate depends on several factors, including the lipid composition of the particle, the presence of pre-existing lipid hydroperoxides, and the experimental conditions.

Lipid hydroperoxides are primary products of lipid peroxidation. Their presence can influence the subsequent progression of oxidative reactions.

Reduced effectiveness of ascorbic acid

Ascorbic acid is a water-soluble antioxidant that can participate in the control of oxidative reactions at aqueous and lipid–water interfaces. Its antioxidant activity depends on the chemical environment, the availability of other antioxidant systems, and the mechanisms responsible for initiating oxidation.

In the study, LDL with higher cholesterol content showed increased resistance to the antioxidative effect of ascorbic acid. This finding does not mean that vitamin C has no antioxidant activity. Instead, it indicates that its ability to inhibit LDL oxidation may vary according to the biochemical properties of the LDL particle.

The importance of lipid composition

The results highlight the importance of considering the complete biochemical environment of LDL. Cholesterol content, oxidizable lipid substrates, and pre-existing oxidation products may collectively influence the progression of lipid peroxidation.

Consequently, the oxidation susceptibility of LDL cannot be explained by cholesterol concentration alone.

The Role of Computer Simulation in Understanding LDL Oxidation

An important feature of the study was the use of computer simulation to investigate the theoretical basis of the experimental findings.

The researchers examined whether a mathematical model of LDL oxidation could reproduce the observed differences in oxidation kinetics and antioxidant effectiveness.

Their simulations indicated that two factors were particularly important:

The initial level of lipid hydroperoxides: Pre-existing oxidation products can affect the subsequent progression of oxidative reactions.

The amount of oxidizable lipid substrate: The quantity of lipids available for oxidation influences the potential course of lipid peroxidation.

The researchers found that incorporating these factors into the model provided a satisfactory fit to the experimental data.

This approach illustrates how computational modeling can complement laboratory experiments. Simulations help researchers evaluate proposed mechanisms, identify influential variables, and explore explanations for complex biochemical observations.

Nevertheless, a successful simulation is not, by itself, proof that the same mechanism operates identically in living humans. Model conclusions depend on the assumptions, parameters, and experimental data used to construct the simulation.

LDL Oxidation and Atherosclerosis

Atherosclerosis is a chronic disease characterized by the accumulation of lipids, inflammatory cells, and other components within the arterial wall.

LDL plays a central role in atherosclerotic disease. When ApoB-containing lipoproteins enter and become retained within the arterial wall, they can undergo modifications that contribute to local inflammatory responses.

Oxidatively modified LDL has been studied extensively because of its potential effects on vascular cells and macrophages.

A simplified overview of the process is:

1. LDL particles circulate in the bloodstream.

2. ApoB-containing lipoproteins enter and become retained within susceptible regions of the arterial wall.

3. Lipoproteins undergo chemical and enzymatic modifications, which may include oxidation.

4. Modified lipoproteins contribute to inflammatory signaling and macrophage lipid accumulation.

5. Foam cells and other components of the lesion contribute to the development of atherosclerotic plaques.

Oxidation is only one aspect of this process. Atherosclerosis also involves lipoprotein retention, immune responses, endothelial biology, and multiple metabolic factors.

The Mosinger study contributes to this field by examining how the internal composition of LDL may influence its behavior during oxidative reactions.

Why Did the Study Matter for Antioxidant Research?

Antioxidants have been investigated as potential approaches to limiting oxidative damage. However, experimental evidence that an antioxidant inhibits oxidation in a laboratory system does not automatically establish that supplementation will prevent cardiovascular events.

The study offered a possible mechanistic explanation for some of the difficulties encountered when attempting to inhibit atherosclerosis through antioxidant administration. If LDL particles differ in their susceptibility to oxidation and in their response to antioxidants, the protective effect observed under one set of conditions may not be reproduced under another.

Several additional factors are important when translating these findings into clinical practice:

Antioxidant concentration and bioavailability.

The location and timing of oxidative reactions.

The chemical composition of lipoprotein particles.

Interactions between antioxidant systems.

The underlying biological mechanisms contributing to atherosclerosis.

Clinical trials of antioxidant supplementation have produced mixed results. The findings of this particular study should therefore be interpreted as mechanistic evidence rather than proof that antioxidant supplementation can prevent or treat cardiovascular disease.

Experimental Findings Versus Clinical Evidence

Understanding the type of evidence provided by the study is essential for accurate interpretation.

These observations do not establish that increasing the cholesterol content of individual LDL particles directly causes cardiovascular disease in humans. Nor do they demonstrate that vitamin C supplementation reduces or increases cardiovascular risk.

Conclusion

The study Higher cholesterol in human LDL is associated with the increase of oxidation susceptibility and the decrease of antioxidant defence: experimental and simulation data demonstrates that LDL oxidation can be influenced by the biochemical composition of the lipoprotein particle.

The experimental results associated higher LDL cholesterol content with faster oxidation and reduced susceptibility to the antioxidative effect of ascorbic acid. Computer simulations further suggested that pre-existing lipid hydroperoxides and the amount of oxidizable lipid substrate were important factors in explaining the observed oxidation kinetics.

Together, these findings emphasize the value of combining biochemical experiments with computational modeling to investigate lipid peroxidation and oxidative stress.

Further research is needed to clarify how these mechanisms operate in vivo and how they relate to cardiovascular outcomes. The study provides mechanistic insight into LDL oxidation, but it does not establish antioxidant supplementation as a proven strategy for preventing atherosclerosis.

Scientific Reference

Mosinger BJ. Higher cholesterol in human LDL is associated with the increase of oxidation susceptibility and the decrease of antioxidant defence: experimental and simulation data.

Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease.

PubMed PMID: 9989258.

DOI: 10.1016/S0925-4439(98)00100-8.

Reference links:

PubMed: https://pubmed.ncbi.nlm.nih.gov/9989258/

DOI: https://doi.org/10.1016/S0925-4439(98)00100-8

Medical and scientific note: This article summarizes mechanistic research and is intended for educational purposes. It does not replace medical advice or establish recommendations for individual cholesterol management.